CYP3A4 and tuberculosis: Furthermore, there might be an interaction of TB treatment drugs and second-line antiretroviral therapy; rifampicin, a potent cytochrome P450 3A4 liver enzyme inducer, which significantly reduces the serum levels of the PIs drugs and reduce the rate of viral re-suppression.